QDQ. Thai Dinh

Q. Thai Dinh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Q. Thai Dinh has a total of 127 co-authors. Here are the top co-authors by number of shared publications:

  • David Alexander Groneberg

    Institute of Occupational Medicine, Social Medicine and Environmental Medicine, Goethe University Frankfurt, 60590 Frankfurt, Germany

    10 shared publications
  • A. Fischer

    Department of Pneumology and Immunology, Allergy‐Centre‐Charité, Otto‐Heubner‐Centre, Clinical Research Unit of Allergy, Berlin, Germany

    7 shared publications
  • B. F. Klapp

    Department of Internal Medicine, Berlin, Germany

    6 shared publications
  • Ervin Cerciz Mingomataj

    Department of Allergology and Clinical Immunology, Mother Theresa School of Medicine, Tirana, Albania

    6 shared publications
  • Axel Fischer

    Clinical Research Unit of Allergy, Charité Campus-Virchow, Charité School of Medicine, Humboldt University, Berlin, Germany

    5 shared publications
  • Burghard F. Klapp

    Department of Internal Medicine, Charité School of Medicine, Humboldt University, Augustenburger Platz 1, 13353 Berlin, Germany

    4 shared publications

Latest Publications

  • Open Access

    Transcriptional down-regulation of suppressor of cytokine signaling (SOCS)-3 in chronic obstructive pulmonary disease

    by Jochen Springer, Frank R Scholz, Christian Peiser, Q Thai Dinh, Axel Fischer, David Quarcoo, David A Groneberg

    Background: Tobacco is a leading environmental factor in the initiation of respiratory diseases and causes chronic obstructive pulmonary disease (COPD). Suppressor of cytokine signaling (SOCS) family members are involved in the pathogenesis of many inflammatory diseases and SOCS-3 has been shown to play an important role in the regulation, onset and maintenance of airway allergic inflammation indicating that SOCS-3 displays a potential therapeutic target for anti-inflammatory respiratory drugs development. Since chronic obstructive pulmonary disease (COPD) is also characterized by inflammatory changes and airflow limitation, the present study assessed the transcriptional expression of SOCS-3 in COPD. Methods: Real-time PCR was performed to assess quantitative changes in bronchial biopsies of COPD patients in comparison to unaffected controls. Results: SOCS-3 was significantly down-regulated in COPD at the transcriptional level while SOCS-4 and SOCS-5 displayed no change. Conclusions: It can be concluded that the presently observed inhibition of SOCS-3 mRNA expression may be related to the dysbalance of cytokine signaling observed in COPD.


  • Open Access

    Mobile Air Quality Studies (MAQS)-an international project

    by David A Groneberg, Cristian Scutaru, Mathias Lauks, Masaya Takemura, Tanja C Fischer, Silvana Kölzow, Anke van Mark, Stefanie Uibel, Ulrich Wagner, Karin Vitzthum, et al.

    Due to an increasing awareness of the potential hazardousness of air pollutants, new laws, rules and guidelines have recently been implemented globally. In this respect, numerous studies have addressed traffic-related exposure to particulate matter using stationary technology so far. By contrast, only few studies used the advanced technology of mobile exposure analysis. The Mobile Air Quality Study (MAQS) addresses the issue of air pollutant exposure by combining advanced high-granularity spatial-temporal analysis with vehicle-mounted, person-mounted and roadside sensors. The MAQS-platform will be used by international collaborators in order 1) to assess air pollutant exposure in relation to road structure, 2) to assess air pollutant exposure in relation to traffic density, 3) to assess air pollutant exposure in relation to weather conditions, 4) to compare exposure within vehicles between front and back seat (children) positions, and 5) to evaluate "traffic zone"-exposure in relation to non-"traffic zone"-exposure. Primarily, the MAQS-platform will focus on particulate matter. With the establishment of advanced mobile analysis tools, it is planed to extend the analysis to other pollutants including NO2, SO2, nanoparticles and ozone.


    • 1 January 2009
      • Vol. 19  (4) , 266-75

    Cough as a symptom and a disease entity: scientometric analysis and density-equalizing calculations.

    by B Groneberg-Kloft, Q Thai Dinh, C Scutaru, T Welte, A Fischer, K Fan Chung, D Quarcoo

    Cough is a prominent symptom of many allergic diseases and a major health burden but there is little information available on the current state of research in this area. To analyze long-term developments in cough research and recent trends. We searched the Thomson Reuters Web of Science databases for cough-related items published between 1900 and 2007 and analyzed the results using scientometric methods and density-equalizing calculations. We found 12 960 cough-related publications from 132 countries for the period studied. The most productive country was the United States of America (USA), followed by the United Kingdom (UK), France, Japan, Canada, and Germany. These 12 960 published items were cited 165 868 times. The average number of citations per item increased from 1976 to 1992, with peaks in 1977, 1979, 1981, 1984, 1989 and 1992. Each of these years was followed by a decrease in citation numbers. Bilateral and multilateral cooperation analysis using the radar chart technique showed a progressive increase in international co-authorship starting at the beginning of the 1990s, with a leading role by the USA and the UK. We detected a marked increased in cough-related research starting in the 1990s. While the majority of data originates from the US, other countries have taken a leading position in terms of research quality (number of citations per item).


  • Trigeminal nasal-specific neurons respond to nerve growth factor with substance-P biosynthesis

    by E. Mingomataj, Q. T. Dinh, D. Groneberg, W. Feleszko, B. Schmeck, R. Joachim, O. Noga, S. Nagel, B. F. Klapp, A. Fischer

    Nerve growth factor (NGF) has been found to induce substance-P biosynthesis in large-diameter A-fibres vagal airway neurons. However, the effect of NGF on trigeminal neurons innervating the nasal mucosa of the mouse has not been investigated so far.NGF has been implicated in allergic diseases by modulating sensory nerves. Therefore, the present study investigated the effect of NGF on neuropeptides expression such as substance-P and glutamate in nasal trigeminal neurons.Using neuronal tracing in combination with double labelling immunohistochemistry the expression of substance-P, glutamate and neurofilament protein 68-kDa expression was examined in nasal-specific trigeminal neurons of BALB/c-mice.The numbers of Fast blue-labelled trigeminal neurons expressing substance-P were significantly increased after NGF exposure (NGF-treated ganglia: 16.4 +/- 0.6% vs. control: 7.0 +/- 0.4%, P<or=0.001). NGF treatment-induced substance-P biosynthesis in neurofilament-positive (NGF-treated ganglia: 8.6 +/- 0.2% vs. control: 1.1 +/- 0.2%, P<or=0.001) as well as neurofilament-negative (NGF-treated ganglia: 7.8 +/- 0.6% vs. control: 5.9 +/- 0.4%, P=0.05) and non-glutamatergic neurons (NGF-treated ganglia: 11.8 +/- 1.9% vs. control 1.1 +/- 1.0%, P<or=0.001) 24 h after NGF exposure.Under normal conditions, substance-P was expressed in nasal-specific neurofilament-negative, glutamatergic and C-fibre neurons. Nasal-specific trigeminal neurons respond to NGF treatment with substance-P biosynthesis in non-glutamatergic, neurofilament-positive as well as -negative neurons. These findings suggest that nasal-specific trigeminal neurons are composed of heterogenous subpopulations in relation to their peptide profiles and therefore may have different functions in neurogenic airway inflammation.


  • Open Access

    Analysis and evaluation of environmental tobacco smoke exposure as a risk factor for chronic cough

    by Beatrix Groneberg-Kloft, Wojciech Feleszko, Quoc T Dinh, Anke van Mark, Elke Brinkmann, Dirk Pleimes, Axel Fischer

    Exposure to environmental tobacco smoke (ETS) and active tobacco smoking has been shown to increase symptoms of bronchial asthma such as bronchoconstriction but effects on other respiratory symptoms remain poorly assessed. Current levels of exposure to tobacco smoke may also be responsible for the development of chronic cough in both children and adults. The present study analyses the effects of tobacco smoke exposure as potential causes of chronic cough. A panel of PubMed-based searches was performed relating the symptom of cough to various forms of tobacco smoke exposure. It was found that especially prenatal and postnatal exposures to ETS have an important influence on children's respiratory health including the symptom of cough. These effects may be prevented if children and pregnant women are protected from exposure to ETS. Whereas the total number of studies adressing the relationship between cough and ETS exposure is relatively small, the present study demonstrated that there is a critical amout of data pointing to a causative role of environmental ETS exposure for the respiratory symptom of cough. Since research efforts have only targeted this effect to a minor extent, future epidemiological and experimental studies are needed to further unravel the relation between ETS and cough.


  • Open Access

    Inhibition of citric acid- and capsaicin-induced cough by novel TRPV-1 antagonist, V112220, in guinea-pig

    by Sum Yee Leung, Akio Niimi, Alison S Williams, Puneeta Nath, F-Xavier Blanc, Q Thai Dinh, K Fan Chung

    Cough reflex can be induced by the pepper extract capsaicin and by low pH in guinea-pig airways. Transient receptor potential vanniloid-1 (TPRV-1) is expressed in the sensory and afferent nerve fibres in airways. We hypothesized that a novel pyridazinylpiperazine analog TPRV-1 inhibitor can effectively reduce cough reflex stimulated by citric acid and capsaicin. Guinea pigs were injected with specific TPRV-1 inhibitor, V112220, a pyridazinylpiperazine analog of N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl) tetrahydropyrazine-1(2H)-carbox-amide (BCTC) (3 mg/kg) intra-peritoneally. One hour before cough response assessment. Coughs were recorded using a recorder system that identified cough sound and accompanying expiratory flows, distinct from sneezes. Guinea-pigs exposed to citric acid (0.4 M) and to capsaicin (10-4M) aerosols, in succession separately by 2 hours. V112220 significantly inhibited the number of coughs induced by citric acid (73 ± 11%, p < 0.01) and capsaicin (70 ± 9.4%, p < 0.05) compared to vehicle control. A novel pyridazinylpiperazine analog TPRV-1 inhibitor can inhibit the cough reflex, induced by both low pH and capsaicin, suggesting that it could be clinically beneficial in treatment of cough.


  • Gene and protein expression of protease‐activated receptor 2 in structural and inflammatory cells in the nasal mucosa in seasonal allergic rhinitis

    by Q. T. Dinh, A. Cryer, M. Trevisani, S. Dinh, S. Wu, L. B. Cifuentes, W. K. Feleszko, A. Williams, P. Geppetti, K. Fan Chung, et al.

    Summary: Background Protease‐activated receptor 2 (PAR 2) has been shown to be responsible for trypsin and mast cell tryptase‐induced airway inflammation. Here, the present study aimed to explore the expression of PAR 2 in the nasal mucosa of seasonal allergic rhinitis (SAR).Methods Study subjects were recruited for the study by medical history, physical examination and laboratory screening tests. Using immunohistochemistry, laser‐assisted cell picking and subsequently real‐time PCR, nasal mucosa biopsies of SAR patients were investigated for PAR 2 gene and protein expression in complex tissues of the nasal mucosa.Results Gene and protein expression of PAR 2 was firstly detected in nasal mucosa of SAR patients. The relative gene expression level of PAR 2 was significantly increased in complex tissues of the nasal mucosa of SAR (6.21±4.02 vs. controls: 1.38±0.86, P=0.004). Moreover, PAR 2 mRNA expression in epithelial cells (SAR: 4.78±4.64 vs. controls: 0.84±0.61, P=0.003) but not in mucus (SAR: 1.51±1.15 vs. controls: 1.35±1.02, P=0.78) and endothelial cells (SAR: 1.20±0.57 vs. controls: 1.73±1.30, P=0.5) was found to be significantly changed in the nasal mucosa in SAR. Using double immunohistochemistry the present study demonstrated that the total numbers of mast cells (P=0.0003) and eosinophils (P=0.03) and the numbers of eosinophils expressing PAR 2 (P=0.006) were significantly elevated in the nasal mucosa of SAR compared with the controls.Conclusion The abundant presence and distribution of gene and protein expression of PAR 2 in different cell types in the nasal mucosa under normal situation, the increased expression of PAR 2 in epithelial cells and the increased number of eosinophils with PAR 2 suggest that PAR 2 may contribute to the pathogenesis of allergic diseases such as SAR.


  • Transcriptional up‐regulation of histamine receptor‐1 in epithelial, mucus and inflammatory cells in perennial allergic rhinitis

    by Q. T. Dinh, A. Cryer, S. Dinh, C. Peiser, S. Wu, J. Springer, E. Hamelmann, B. F. Klapp, W. Heppt, A. Fischer

    Summary: BackgroundHistamine receptors play an important role in the pathogenesis of nasal allergy. Activation of histamine receptor 1 (H1R) and 2 (H2R) can cause allergic symptoms which can be blocked effectively by antihistamines. H1R and H2R transcript levels have been found to be up‐regulated in perennial – but not in seasonal – allergic rhinitis (AR). The present study aimed to explore H1R and H2R expression in complex tissues of the nasal mucosa of perennial allergic rhinitis (PAR).MethodsTen patients with PAR and 13 non‐AR subjects were recruited for the study by medical history, physical examination and laboratory screening tests. In this study, we have analysed single cells dissected from the nasal mucosa biopsies by laser‐assisted microdissection. H1R mRNA expression was analysed in different cell types such as epithelial, endothelial, mucus and inflammatory cells isolated from the nasal mucosa of PAR in comparison with non‐AR subjects.ResultsH1R mRNA gene expression level was significantly increased in the nasal mucosa of PAR in comparison with non‐AR (PPPP=0.23). Interestingly, inflammatory cells in the nasal mucosa of PAR patients were also strongly expressed H1R mRNA (PConclusionThe present study indicates that PAR alters the expression of H1R mRNA in epithelial, mucus and inflammatory cells of the nasal mucosa and but not in endothelial cells. Therefore, epithelial, mucus and inflammatory cells may play an important role in histamine‐mediated allergic airway inflammation in PAR.


  • Protease-activated receptor 2 expression in trigeminal neurons innervating the rat nasal mucosa

    by Q. Thai Dinh, Annette Cryer, Stephen Dinh, Marcello Trevisani, Petra Georgiewa, Fan Chung, Pierangelo Geppetti, Werner Heppt, Burghard F. Klapp, Axel Fischer


  • Allergic airway inflammation induces tachykinin peptides expression in vagal sensory neurons innervating mouse airways

    by Q. T. Dinh, E. Mingomataj, D. Quarcoo, D. A. Groneberg, C. Witt, B. F. Klapp, A. Braun, A. Fischer

    Summary: Background Allergic airway inflammation has been shown to induce pro‐inflammatory neuropeptides such as tachykinin peptides substance P (SP) and neurokinin A (NKA) together with related peptide like calcitonin gene‐related peptide (CGRP) in nodose sensory neurons innervating guinea‐pig airways.Objective The present study was designed to examine the effects of allergen sensitization and challenge on the SP/NKA expression in the jugular–nodose ganglion neurons innervating the murine airways.Methods Using retrograde neuronal tracing technique in combination with double‐labelling immunohistochemistry, the expression of SP/NKA was investigated in a murine model of allergic airway inflammation.Results Allergic airway inflammation was found to induce the expression of SP/NKA (13.2±1.43% vs. 5.8±0.37%, P20 μm) vagal sensory neurons retrograde labelled with Fast blue dye from the main stem bronchi.Conclusion Based on the induction of tachykinins in airway‐specific large‐sized jugular–nodose ganglia neurons by allergic airway inflammation, the present study suggests that allergen sensitization and challenge may lead to de novo induction of tachykinins in neurons. This may partly contribute to the pathogenesis of airways diseases such as allergic airway inflammation.